Terns Pharmaceuticals
TERN
TERN
137 hedge funds and large institutions have $229M invested in Terns Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 39 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
44% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 43
52% less capital invested
Capital invested by funds: $477M → $229M (-$248M)
Holders
137
Holding in Top 10
3
Calls
$989K
Puts
$410K
Top Buyers
| 1 | +$10.4M | |
| 2 | +$2.24M | |
| 3 | +$1.77M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.7M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.47M |
Top Sellers
| 1 | -$5.97M | |
| 2 | -$5.88M | |
| 3 | -$4.17M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.94M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.01M |
